These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1353452

  • 21. GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain.
    Contreras PC, Bremer ME, Rao TS.
    Life Sci; 1990; 47(22):PL133-7. PubMed ID: 1980329
    [Abstract] [Full Text] [Related]

  • 22. Remoxipride and raclopride differ from metoclopramide by their effects on striatal dopamine release and biosynthesis in rats.
    Guinetdinov RR, Bogdanov MB, Kudrin VS, Rayevsky KS.
    Neuropharmacology; 1994 Feb; 33(2):215-9. PubMed ID: 7913539
    [Abstract] [Full Text] [Related]

  • 23. Brain sigma receptors labelled by [3H]nemonapride.
    Helmeste D, Tang SW, Fang H, Li M.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):R1-3. PubMed ID: 8773467
    [Abstract] [Full Text] [Related]

  • 24. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
    Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF.
    Proc Natl Acad Sci U S A; 1986 Nov 22; 83(22):8784-8. PubMed ID: 2877462
    [Abstract] [Full Text] [Related]

  • 25. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM, O'Shea RD, Manallack DT.
    J Neurochem; 1989 Sep 22; 53(3):779-88. PubMed ID: 2569504
    [Abstract] [Full Text] [Related]

  • 26. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T, Mikuni M, Higuchi T, Arai I, Takahashi K, Yamauchi T.
    Life Sci; 1990 Sep 22; 47(6):531-7. PubMed ID: 2402179
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H, Wedel I, Halldin C, Kopp J, Farde L.
    J Neurochem; 1990 Dec 22; 55(6):2048-57. PubMed ID: 1977888
    [Abstract] [Full Text] [Related]

  • 28. Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys.
    Gerlach J, Casey DE.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Dec 22; 14(1):103-12. PubMed ID: 1967845
    [Abstract] [Full Text] [Related]

  • 29. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR, Budygin EA, Kovalev GI, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1992 Jul 22; 114(7):47-9. PubMed ID: 1358258
    [Abstract] [Full Text] [Related]

  • 30. Neuropharmacological and behavioural properties of remoxipride in the rat.
    Ogren SO, Florvall L, Hall H, Magnusson O, Angeby-Möller K.
    Acta Psychiatr Scand Suppl; 1990 Jul 22; 358():21-6. PubMed ID: 1978483
    [Abstract] [Full Text] [Related]

  • 31. (+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo.
    Iyengar S, Wood PL, Mick SJ, Dilworth VM, Gray NM, Farah JM, Rao TS, Contreras PC.
    Neuropharmacology; 1991 Aug 22; 30(8):915-22. PubMed ID: 1723511
    [Abstract] [Full Text] [Related]

  • 32. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ.
    Psychopharmacology (Berl); 1991 Aug 22; 105(3):421-7. PubMed ID: 1686818
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
    Allard P, Eriksson K, Ross SB, Marcusson JO.
    Psychopharmacology (Berl); 1990 Aug 22; 102(3):291-4. PubMed ID: 1979175
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats.
    Clifton PG, Rusk IN, Cooper SJ.
    Behav Neurosci; 1991 Apr 22; 105(2):272-81. PubMed ID: 1675060
    [Abstract] [Full Text] [Related]

  • 37. (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to sigma receptors in mouse brain in vivo.
    Koe BK, Burkhart CA, Lebel LA.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):263-6. PubMed ID: 2566491
    [Abstract] [Full Text] [Related]

  • 38. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF.
    Neuroendocrinology; 1988 Aug 28; 48(2):188-200. PubMed ID: 2975769
    [Abstract] [Full Text] [Related]

  • 39. Involvement of D1 dopamine receptors in the control of TSH secretion in the male rat.
    Andersson K.
    Acta Physiol Scand; 1989 Apr 28; 135(4):449-57. PubMed ID: 2567562
    [Abstract] [Full Text] [Related]

  • 40. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T, Ström P, de Paulis T, Stensland B, Csöregh I, Lundin K, Hall H, Ogren SO.
    J Med Chem; 1991 Mar 28; 34(3):948-55. PubMed ID: 1672158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.